Detalhe da pesquisa
1.
Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma.
N Engl J Med
; 389(21): 1961-1971, 2023 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870920
2.
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study.
Lancet Oncol
; 23(2): 248-258, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35030333
3.
Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial.
Lancet Oncol
; 23(5): 650-658, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35421369
4.
Safety and Efficacy of Atezolizumab in Understudied Populations with Pretreated Urinary Tract Carcinoma: Subgroup Analyses of the SAUL Study in Real-World Practice.
J Urol
; 206(2): 240-251, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33835866
5.
PIVOT-10: Phase II study of bempegaldesleukin plus nivolumab in cisplatin-ineligible advanced urothelial cancer.
Future Oncol
; 17(2): 137-149, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32938232
6.
IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance.
J Pathol
; 244(2): 242-253, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29160922
7.
Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?
Br J Cancer
; 119(4): 389-407, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30061587
8.
Circulating Tumour DNA in Muscle-Invasive Bladder Cancer.
Int J Mol Sci
; 19(9)2018 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30158468
9.
Multi-stage genome-wide association study identifies new susceptibility locus for testicular germ cell tumour on chromosome 3q25.
Hum Mol Genet
; 24(4): 1169-76, 2015 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25281660
10.
Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomy.
BJU Int
; 120(5): 639-650, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28453896
11.
The delineation of intraprostatic boost regions for radiotherapy using multimodality imaging.
Future Oncol
; 12(21): 2495-2511, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27322113
12.
Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer.
N Engl J Med
; 366(16): 1477-88, 2012 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-22512481
13.
Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial.
Lancet Oncol
; 15(4): 464-73, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24581940
14.
Stereotactic body radiotherapy for oligometastases.
Lancet Oncol
; 14(1): e28-37, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23276369
15.
A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trial.
EBioMedicine
; 101: 105032, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38387404
16.
Final Results from SAUL, a Single-arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract Carcinoma.
Eur Urol Focus
; 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38839505
17.
Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium.
Eur J Cancer
; 202: 114042, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38564927
18.
Management of Fibroblast Growth Factor Inhibitor Treatment-emergent Adverse Events of Interest in Patients with Locally Advanced or Metastatic Urothelial Carcinoma.
Eur Urol Open Sci
; 50: 1-9, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37101768
19.
A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact.
Genet Epidemiol
; 35(6): 549-56, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21769933
20.
Minimum regions of genomic imbalance in stage I testicular embryonal carcinoma and association of 22q loss with relapse.
Genes Chromosomes Cancer
; 50(3): 186-95, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21213372